HK1130667A1 - Azithromycin for the treatment of nodular acne - Google Patents
Azithromycin for the treatment of nodular acneInfo
- Publication number
- HK1130667A1 HK1130667A1 HK09108640.8A HK09108640A HK1130667A1 HK 1130667 A1 HK1130667 A1 HK 1130667A1 HK 09108640 A HK09108640 A HK 09108640A HK 1130667 A1 HK1130667 A1 HK 1130667A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- azithromycin
- treatment
- nodular acne
- acne
- nodular
- Prior art date
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract 2
- 206010000496 acne Diseases 0.000 title abstract 2
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 2
- 229960004099 azithromycin Drugs 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84906506P | 2006-10-03 | 2006-10-03 | |
US11/635,127 US7704959B2 (en) | 2006-10-03 | 2006-12-06 | Azithromycin for the treatment of nodular acne |
PCT/US2007/020583 WO2008042139A2 (en) | 2006-10-03 | 2007-09-24 | Azithromycin for the treatment of nodular acne |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1130667A1 true HK1130667A1 (en) | 2010-01-08 |
Family
ID=39261797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09108640.8A HK1130667A1 (en) | 2006-10-03 | 2009-09-22 | Azithromycin for the treatment of nodular acne |
Country Status (19)
Country | Link |
---|---|
US (2) | US7704959B2 (xx) |
EP (2) | EP2086552B1 (xx) |
JP (1) | JP2010505827A (xx) |
KR (1) | KR20090064592A (xx) |
CN (2) | CN101534837B (xx) |
AT (1) | ATE533496T1 (xx) |
AU (1) | AU2007302663B2 (xx) |
BR (1) | BRPI0719535A2 (xx) |
CA (1) | CA2664673A1 (xx) |
CY (1) | CY1112650T1 (xx) |
DK (1) | DK2086552T3 (xx) |
ES (2) | ES2377470T3 (xx) |
HK (1) | HK1130667A1 (xx) |
MX (1) | MX2009003484A (xx) |
PL (2) | PL2086552T3 (xx) |
PT (1) | PT2086552E (xx) |
RU (1) | RU2009116629A (xx) |
SI (1) | SI2086552T1 (xx) |
WO (1) | WO2008042139A2 (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8124123B2 (en) * | 2007-09-05 | 2012-02-28 | Dow Pharmaceutical Sciences, Inc. | Controlled release azithromycin solid dosages forms |
US8143227B2 (en) * | 2007-09-05 | 2012-03-27 | Dow Pharmaceutical Sciences, Inc. | Azithromycin for treatment of skin disorders |
CN107281155B (zh) * | 2017-06-06 | 2020-04-10 | 扬子江药业集团四川海蓉药业有限公司 | 一种阿奇霉素片及其制备方法 |
BR112020000968A2 (pt) * | 2017-07-21 | 2020-07-14 | Almirall, Llc | tratamento de lesões não inflamatórias |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU43006B (en) | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
US4474758A (en) | 1981-11-19 | 1984-10-02 | American Cyanamid Company | Haemophilus influenzae type b and pertussis outer membrane component combined vaccine |
US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
US4474766A (en) | 1983-06-27 | 1984-10-02 | Merck & Co., Inc. | Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID) |
MX12213A (es) | 1987-07-09 | 1993-05-01 | Pfizer | Metodo de preparacion de dihidrato de azitromicina cristalino |
FR2710841B1 (fr) | 1993-10-05 | 1995-11-17 | Oreal | Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau. |
GB9723669D0 (en) | 1997-11-07 | 1998-01-07 | Univ Aberdeen | Skin penetration enhancing components |
CA2719162C (en) * | 2001-04-05 | 2014-12-23 | Galderma Pharma S.A. | Methods of treating acne |
US7211267B2 (en) | 2001-04-05 | 2007-05-01 | Collagenex Pharmaceuticals, Inc. | Methods of treating acne |
HRP20010301A2 (en) * | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
US9035741B2 (en) * | 2003-06-27 | 2015-05-19 | Stryker Corporation | Foot-operated control console for wirelessly controlling medical devices |
-
2006
- 2006-12-06 US US11/635,127 patent/US7704959B2/en not_active Expired - Fee Related
-
2007
- 2007-09-24 CN CN2007800406070A patent/CN101534837B/zh not_active Expired - Fee Related
- 2007-09-24 PT PT07838730T patent/PT2086552E/pt unknown
- 2007-09-24 WO PCT/US2007/020583 patent/WO2008042139A2/en active Application Filing
- 2007-09-24 CA CA002664673A patent/CA2664673A1/en not_active Abandoned
- 2007-09-24 AT AT07838730T patent/ATE533496T1/de active
- 2007-09-24 ES ES07838730T patent/ES2377470T3/es active Active
- 2007-09-24 EP EP07838730A patent/EP2086552B1/en not_active Not-in-force
- 2007-09-24 KR KR1020097008632A patent/KR20090064592A/ko not_active Application Discontinuation
- 2007-09-24 RU RU2009116629/15A patent/RU2009116629A/ru unknown
- 2007-09-24 SI SI200730804T patent/SI2086552T1/sl unknown
- 2007-09-24 JP JP2009531388A patent/JP2010505827A/ja active Pending
- 2007-09-24 BR BRPI0719535-4A patent/BRPI0719535A2/pt not_active IP Right Cessation
- 2007-09-24 ES ES11188960.6T patent/ES2574677T3/es active Active
- 2007-09-24 PL PL07838730T patent/PL2086552T3/pl unknown
- 2007-09-24 CN CN2012100346744A patent/CN102614210A/zh active Pending
- 2007-09-24 MX MX2009003484A patent/MX2009003484A/es active IP Right Grant
- 2007-09-24 EP EP11188960.6A patent/EP2420240B1/en not_active Not-in-force
- 2007-09-24 AU AU2007302663A patent/AU2007302663B2/en not_active Ceased
- 2007-09-24 DK DK07838730.5T patent/DK2086552T3/da active
- 2007-09-24 PL PL11188960.6T patent/PL2420240T3/pl unknown
-
2009
- 2009-09-22 HK HK09108640.8A patent/HK1130667A1/xx not_active IP Right Cessation
-
2010
- 2010-04-23 US US12/799,401 patent/US20100216732A1/en not_active Abandoned
-
2012
- 2012-01-17 CY CY20121100054T patent/CY1112650T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010505827A (ja) | 2010-02-25 |
EP2086552A2 (en) | 2009-08-12 |
AU2007302663B2 (en) | 2012-07-12 |
RU2009116629A (ru) | 2010-11-10 |
EP2420240B1 (en) | 2016-05-11 |
CN102614210A (zh) | 2012-08-01 |
WO2008042139A2 (en) | 2008-04-10 |
US20080081790A1 (en) | 2008-04-03 |
CY1112650T1 (el) | 2016-02-10 |
MX2009003484A (es) | 2009-10-26 |
DK2086552T3 (da) | 2012-01-09 |
KR20090064592A (ko) | 2009-06-19 |
US7704959B2 (en) | 2010-04-27 |
ATE533496T1 (de) | 2011-12-15 |
WO2008042139A3 (en) | 2008-10-16 |
EP2086552A4 (en) | 2009-11-04 |
ES2377470T3 (es) | 2012-03-27 |
PL2420240T3 (pl) | 2016-10-31 |
CN101534837B (zh) | 2012-04-04 |
CN101534837A (zh) | 2009-09-16 |
AU2007302663A1 (en) | 2008-04-10 |
ES2574677T3 (es) | 2016-06-21 |
EP2086552B1 (en) | 2011-11-16 |
PT2086552E (pt) | 2011-12-19 |
US20100216732A1 (en) | 2010-08-26 |
BRPI0719535A2 (pt) | 2014-01-14 |
CA2664673A1 (en) | 2008-04-10 |
EP2420240A1 (en) | 2012-02-22 |
SI2086552T1 (sl) | 2012-01-31 |
PL2086552T3 (pl) | 2012-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2018023I1 (xx) | ||
PT2368550E (pt) | Modulador do receptor de androgénios para o tratamento de cancro da próstata e doenças associadas ao receptor de androgénios | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
AU2003220553A1 (en) | Combination therapy for the treatment of conditions with pathogenic inflammatory components | |
MX2007000611A (es) | Tratamiento de la piel con luz y un agente benefico para mitigar el acne. | |
MX2008007808A (es) | Analogos de rifamicina y usos de ellos. | |
HK1130667A1 (en) | Azithromycin for the treatment of nodular acne | |
IL229594A0 (en) | Materials and preparations for the treatment of tumors | |
NO20092496L (no) | Ny terapeutisk anvendelse for behandling av leukemi | |
HK1097033A1 (en) | Lighting appliance with a reduced encumbrance | |
WO2007012870A3 (en) | Use of nefopam for the treatment of affective disorders | |
WO2010149688A3 (en) | Antitumoral compounds | |
ZA200706151B (en) | Adapalene for the long-term treatment of acne vulgaris | |
WO2007044679A3 (en) | Treating metabolic syndrome with 2-deoxy-d-glucose | |
UA29550U (xx) | Сполука 1-(1',1'-дифтор-2'-бром-2'-хлоретил)-5-бромурацил з потенційними фізіологічними властивостями[соединение 1-(1',1'-дифтор-2'-бром-2'-хлоретил)-5-бромурацил с потенциальными физиологическими свойствами | |
GB0620005D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180921 |